Enhanced Fe( ii )-artemisinin-mediated chemodynamic therapy with efficient Fe( iii )/Fe( ii ) conversion circulation for cancer treatment
Biomaterials Science · 2024
DOI: 10.1039/d4bm01095g ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials Science, 2024. Verfasst von Xiao Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, School of Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Nanjing 210023, PR …. Hauptthemen laut MEDLINE: Artemisinins, Antineoplastic Agents, Nanoparticles, Silicon Dioxide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: State Administration of Foreign Experts Affairs, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Existing strategies to investigate the antitumor effects of artemisinin and its derivatives (ART) are inadequate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, School of Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Nanjing 210023, PR China.
- Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, Center for Analysis and Testing, China Pharmaceutical University, 639 L…
Förderung
- State Administration of Foreign Experts Affairs
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Xu, X., Wang, Y., Yan, D., Ren, C., Cai, Y., Liao, S., Kong, L., & Han, C. (2024). Enhanced Fe( ii )-artemisinin-mediated chemodynamic therapy with efficient Fe( iii )/Fe( ii ) conversion circulation for cancer treatment. Biomaterials Science. https://doi.org/10.1039/d4bm01095g
Vancouver
Xu X, Wang Y, Yan D, Ren C, Cai Y, Liao S, et al. Enhanced Fe( ii )-artemisinin-mediated chemodynamic therapy with efficient Fe( iii )/Fe( ii ) conversion circulation for cancer treatment. Biomaterials Science. 2024. doi:10.1039/d4bm01095g
BibTeX
@article{Xu2024,
author = {Xu, Xiao and Wang, Yun and Yan, Dan and Ren, Chunling and Cai, Yuqian and Liao, Shanting and Kong, Lingyi and Han, Chao},
title = {Enhanced Fe( ii )-artemisinin-mediated chemodynamic therapy with efficient Fe( iii )/Fe( ii ) conversion circulation for cancer treatment},
journal = {Biomaterials Science},
year = {2024},
doi = {10.1039/d4bm01095g}
}
EUVIMED